南微医学 (688029.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(南微医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 598,189,818.44597,035,164.49550,099,785.64468,041,833.96551,809,768.89517,601,645.53442,690,227.21
 营业收入(元) 598,189,818.44597,035,164.49550,099,785.64468,041,833.96551,809,768.89517,601,645.53442,690,227.21
二、营业总成本(元) 465,413,347.47396,738,627.26431,106,919.12388,524,499.68435,292,455.66418,529,294.48393,863,563.17
 营业成本(元) 211,621,586.14211,689,426.97204,230,317.38178,244,827.43215,381,369.21210,059,754.83169,560,905.68
 研发费用(元) 33,929,155.1533,273,426.3735,400,007.8643,627,911.6737,900,585.5743,191,314.1040,606,208.52
 营业税金及附加(元) 6,639,432.725,499,336.575,118,784.293,775,117.115,613,367.193,027,213.393,562,243.81
 销售费用(元) 129,773,461.51141,748,022.33111,180,111.27125,428,664.85115,361,810.39103,762,248.6088,706,290.84
 管理费用(元) 73,998,165.3476,052,423.3976,252,615.0248,560,979.4589,659,938.3785,264,372.0985,584,445.68
 财务费用(元) 9,451,546.61-71,524,008.36-1,074,916.71-11,113,000.83-28,624,615.07-26,775,608.535,843,468.64
  其中:利息费用(元) 263,978.65106,671.01157,803.15591,884.94649,905.07-39,885.17195,151.63
  其中:利息收入(元) 14,260,638.1312,547,378.378,513,944.055,194,711.054,685,942.761,797,771.932,359,580.40
 资产减值损失(元) -4,501,100.24-8,876,866.74-1,489,080.26-11,857,317.70-3,428,279.02-5,830,442.00-928,587.71
 信用减值损失(元) 5,484,472.24-5,676,689.40-1,385,180.49697,185.69-756,114.28-664,143.56-261,711.49
三、其他经营收益
 加:公允价值变动收益(元) 2,163,081.91-1,882,390.262,025,575.00-1,804,114.06-5,752,648.47--
 加:投资收益(元) 4,649,135.2712,034,727.712,290,332.8320,522,697.4213,474,748.965,132,987.213,968,482.58
  其中:对联营企业和合营企业的投资收益(元) 3,213,379.492,515,851.162,212,952.741,533,104.683,960,310.202,376,055.133,370,581.39
 资产处置收益(元) --31,084.12757,491.33-236.28--1,030,953.43
 其他收益(元) --883,346.717,427.95--293,363.18
 营业利润平衡项目(元) --0.01----
四、营业利润(元) 140,572,060.15195,895,318.53121,348,944.4487,840,704.91120,054,784.14105,399,363.8150,867,257.17
 加:营业外收入(元) 1,192,743.88784,637.91698,772.805,064,708.892,707,731.05594,154.301,150,782.29
 减:营业外支出(元) 551,130.224,522,650.4358,982.37523,864.31185,105.754,849,373.66249,013.02
 利润总额平衡项目(元) ---0.01----
五、利润总额(元) 141,213,673.81192,157,306.02121,988,734.8692,381,549.49122,577,409.44101,144,144.4551,769,026.44
 减:所得税费用(元) 17,151,797.1924,538,658.7818,592,577.27-6,667,004.7818,745,640.5116,694,584.506,253,990.62
六、净利润(元) 124,061,876.62167,618,647.24103,396,157.5999,048,554.27103,831,768.9384,449,559.9545,515,035.82
(一)按经营持续性分类
  持续经营净利润(元) 124,061,876.62167,618,647.24103,396,157.5999,048,554.27103,831,768.9384,449,559.9545,515,035.82
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 122,227,957.23162,811,481.65101,486,862.00103,631,501.73102,108,506.7781,477,004.7843,373,430.74
  少数股东损益(元) 1,833,919.394,807,165.591,909,295.59-4,582,947.461,723,262.162,972,555.172,141,605.08
 扣除非经常性损益后的净利润(元) 118,774,662.62159,546,031.0099,177,545.8783,017,800.1397,122,881.4276,362,098.9842,934,651.48
七、每股收益
 一、基本每股收益(元) 0.650.870.540.550.550.340.32
 二、稀释每股收益(元) 0.650.870.540.550.540.340.32
八、其他综合收益(元) -7,028,750.737,380,778.38571,675.969,339,087.16-759,694.61-249,994.351,295,935.13
 归属于母公司股东的其他综合收益(元) -7,029,797.227,388,833.88569,612.789,344,735.34-751,369.34-250,827.611,295,935.13
 归属于少数股东的其他综合收益(元) 1,046.49-8,055.502,063.18-5,648.18-8,325.27--
九、综合收益总额(元) 117,033,125.89174,999,425.62103,967,833.55108,387,641.43103,072,074.3284,199,565.6046,810,970.95
 归属于母公司所有者的综合收益总额(元) 115,198,160.01170,200,315.53102,056,474.78112,976,237.07101,357,137.4381,226,177.1744,669,365.87
 归属于少数股东的综合收益总额(元) 1,834,965.884,799,110.091,911,358.77-4,588,595.641,714,936.892,973,388.432,141,605.08
公告日期 2023-10-282023-08-082023-04-262023-04-262022-10-282022-08-192022-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院